IZUMO2 inhibitors are a class of chemical compounds designed to inhibit the function of the IZUMO2 protein, a crucial factor in sperm-egg fusion during fertilization. The IZUMO2 protein, belonging to the IZUMO family, is found on the surface of sperm cells and is essential for their ability to recognize and bind to the egg's membrane, facilitating fusion. Structurally, these inhibitors often feature complex molecular scaffolds that enable specific binding to the active or functional sites of the IZUMO2 protein, thereby blocking its interaction with its counterpart proteins on the oocyte. This specific binding mechanism may involve mimicking natural substrates or adopting conformations that sterically hinder protein-protein interactions. Their chemical design can range from small molecules to larger peptides, all with the goal of high selectivity and affinity for IZUMO2.
In terms of chemical diversity, IZUMO2 inhibitors vary based on their molecular backbone, functional groups, and interaction dynamics with the IZUMO2 protein surface. Many inhibitors in this class are built to exploit hydrophobic pockets or hydrogen-bonding interactions within the binding domains of IZUMO2, allowing for strong and stable inhibition. Advances in computational modeling and structure-based drug design have facilitated the identification and refinement of these inhibitors, optimizing their binding properties. The chemical properties of IZUMO2 inhibitors are usually fine-tuned to achieve specific interaction profiles, such as minimal off-target effects and optimized physicochemical properties, like solubility and bioavailability. This chemical class thus represents a significant leap in the molecular manipulation of IZUMO2, allowing for precise control over sperm-egg fusion processes through targeted protein inhibition.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
A tyrosine kinase inhibitor; IZUMO2, if phosphorylated, may be impacted by this inhibition. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
ERK pathway inhibitor; if IZUMO2 is involved in pathways influenced by ERK, its function may be affected. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor; can influence pathways that might interact with IZUMO2. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor that can affect pathways potentially associated with IZUMO2. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
Ca2+/calmodulin-dependent protein kinase II inhibitor; could impact any potential Ca2+ signaling involving IZUMO2. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Broad spectrum kinase inhibitor; could influence any potential kinase-related activity of IZUMO2. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Src kinase inhibitor; if IZUMO2 has any Src kinase-related functions, they might be impacted. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor; may affect pathways that could be associated with IZUMO2. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAP kinase inhibitor; can influence any potential association of IZUMO2 with p38 MAPK signaling. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor; might influence pathways that potentially interact with IZUMO2. | ||||||